在冠状动脉和外周动脉疾病中抗血栓治疗的最新情况
1Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL.
Hematology. American Society of Hematology. Education Program
|December 5, 2025
概括
双通道抑制,结合抗血小板和抗血栓治疗,可以改善动脉样硬化心血管疾病 (ASCVD) 患者的心血管结果,包括冠状动脉疾病 (CAD) 和外周动脉疾病 (PAD). 本综述概述了这种治疗方法的患者选择.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样性心血管疾病 (ASCVD) 包括冠状动脉疾病 (CAD) 和外周动脉疾病 (PAD),通常是共存的.
- 血小板激活和血栓生成是ASCVD中急性缺血事件的关键病理生理机制.
- 双通道抑制,即抗血小板和抗血栓剂的组合,是管理ASCVD的新兴策略.
研究的目的:
- 审查双通道抑制在改善ASCVD患者心血管结果中的作用.
- 为了确定患有CAD和PAD的患者,他们可能会从双通道抑制中受益.
- 提供稳定的CAD和下肢PAD的临床表现的概述.
主要方法:
- 文献综述侧重于ASCVD中双通道抑制.
- 对评估抗血小板和抗血小板药物治疗组合的研究分析.
- 关于CAD和PAD表现的临床数据的综合.
主要成果:
- 双通道抑制表明有可能改善ASCVD患者的心血管结果.
- 了解患有CAD和PAD并存的患者个人资料对于治疗选择至关重要.
- 临床介绍CAD和PAD的信息治疗策略.
结论:
- 双通道抑制是选择ASCVD患者的一种有前途的治疗方法.
- 考虑到CAD和PAD共存,个性化治疗策略是必不可少的.
- 进一步的研究可能会完善双通道抑制的患者选择.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
226
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
Coronary Artery Disease V: Interprofessional Care
205
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
205
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Venous Thrombosis III: Interprofessional Care
265
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
Peripheral Artery Disease IV: Nursing Management
321
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
321
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K


